Gout Breakthrough: Canakinumab Offers New Hope for Patients with Kidney Disease
Discover how canakinumab (CAN-PFS) is transforming gout treatment for patients with chronic kidney disease, offering a potent alternative with significant pain relief and a reduced risk of new gout attacks.